Jacobs Levy Equity Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $756K | Sell |
202,570
-292,307
| -59% | -$1.09M | ﹤0.01% | 813 |
|
|
2025
Q1 | $1.37M | Buy |
+494,877
| New | +$1.37M | 0.01% | 747 |
|
|
2022
Q1 | – | Sell |
-55,222
| Closed | -$390K | – | 1087 |
|
|
2021
Q4 | $390K | Sell |
55,222
-32,312
| -37% | -$228K | ﹤0.01% | 865 |
|
|
2021
Q3 | $912K | Buy |
87,534
+69,884
| +396% | +$728K | 0.01% | 766 |
|
|
2021
Q2 | $216K | Buy |
+17,650
| New | +$216K | ﹤0.01% | 975 |
|